They protect tumor cells from lymphocytes by inhibiting the T-cell-mediated cytotoxicity of CD4+ and CD8+ cells in malignancies such as multiple myeloma and breast cancer metastases [15, 16]. This evidence concerns the gene CD4 and neoplasm.